In the wake of the COVID crisis – SPAC’s have become the tool du-jour for firms to go public and access the capital markets instead of going the traditional IPO route.
This webinar led by Private Equity industry experts looks at these unique investment vehicles and how PE managers are using them. It will answer many questions institutional investors have regarding SPACs.
It will cover:
- The use of SPACs in 2020 and beyond by the PE industry
- How SPAC’s operate and are governed
- Regulatory issues surrounding SPACs
- How investors should think about PE firms that invest in SPACs and what it means for them
- Opportunities that exist for institutional investors
A panel discussion looking at why co-investments continue to rise in popularity – particularly in the current climate – as well as at the related benefits and possible pitfalls of co-investments.
Investors with cross-border investment income are often entitled to withholding tax refunds or tax relief at source, depending on several factors, including tax residency, legal status, and the existence of double taxation treaties. However, most investors do not have the knowledge or processing infrastructure to file for reclaims on their own.
This workshop will cover the complexities of the reclamation process, how it is done, and why not paying attention to this aspect of your investment may be a breach of fiduciary duty. Lead by industry expert Len Lipton of GlobeTax. This webinar is not to be missed by investors who look outside of the United States for portfolio returns.
This presentation and panel discussion is a snapshot of what is happening at this specific point in this evolving crisis, focused on its impact on the closed-end fund alternative investment market –specifically for funds and co-investments targeting private equity, performing debt, distressed debt, real estate, infrastructure and natural resources.
An insider’s perspective on intelligence methodologies and specifically how they apply to the investment arena, and how this is changing in the era of COVID-19.
